Cannabix Technologies Inc. (CSE:BLO)

Market Cap	38.80M -43.8%
Revenue (ttm)	n/a
Net Income	-3.82M
EPS	-0.03
Shares Out	123.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	0.3000
Previous Close	0.3000
Day's Range	0.3000 - 0.3150
52-Week Range	0.2900 - 0.9500
Beta	1.53
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 23, 2026

About Cannabix Technologies

Cannabix Technologies Inc. develops marijuana and alcohol breathalyzer technologies for law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) system for tetrahydrocannabinol (THC) detection and quantification, which includes the Cannabix Breath Collection Unit (BCU) and Breath Cartridge (BC) for non-invasive, portable, standardized human breath sample collection, storage, and transportation. The company also provides BreathLogix, an autonomous alcohol screening system for rapid and re...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BLO

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 13, 2026

Data Sources Report a data error